Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Global Dry Eye Syndrome Market by Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Evaporative Dry Eye
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Aqueous Dry Eye
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
Chapter 5 Global Dry Eye Syndrome Market by Treatment Type: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 Nutritional Supplements
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
    5.3 Serum Eye Drops
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
    5.4 Lubricant Eye Drops
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
          5.4.3 Oily Tear Eye Drops
                   5.4.3.1 Market Size and Forecast
          5.4.4 Ointments
                   5.4.4.1 Market Size and Forecast
          5.4.5 Preservative-Free Drops
                   5.4.5.1 Market Size and Forecast
    5.5 Anti-Inflammatory Drugs
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
          5.5.3 Tetracyclines
                   5.5.3.1 Market Size and Forecast
          5.5.4 Corticosteroids
                   5.5.4.1 Market Size and Forecast
Chapter 6 Global Dry Eye Syndrome Market by Geography: Market Size and Forecast, 2015 – 2024
    6.1 Overview
    6.2 North America
          6.2.1 Current Trend and Analysis
          6.2.2 Market Size and Forecast
          6.2.3 U.S.
                   6.2.3.1 Market Size and Forecast
          6.2.4 Canada
                   6.2.4.1 Market Size and Forecast
          6.2.5 Mexico
                   6.2.5.1 Market Size and Forecast
    6.3 Europe
          6.3.1 Current Trend and Analysis
          6.3.2 Market Size and Forecast
          6.3.3 Germany
                   6.3.3.1 Market Size and Forecast
          6.3.4 Italy
                   6.3.4.1 Market Size and Forecast
          6.3.5 United Kingdom
                   6.3.5.1 Market Size and Forecast
          6.3.6 France
                   6.3.6.1 Market Size and Forecast
          6.3.7 Russia
                   6.3.7.1 Market Size and Forecast
          6.3.8 Others
                   6.3.8.1 Market Size and Forecast
    6.4 Asia-Pacific
          6.4.1 Current Trend and Analysis
          6.4.2 Market Size and Forecast
          6.4.3 China
                   6.4.3.1 Market Size and Forecast
          6.4.4 India
                   6.4.4.1 Market Size and Forecast
          6.4.5 Japan
                   6.4.5.1 Market Size and Forecast
          6.4.6 South Korea
                   6.4.6.1 Market Size and Forecast
          6.4.7 Others
                   6.4.7.1 Market Size and Forecast
    6.5 RoW
          6.5.1 Current Trend and Analysis
          6.5.2 Market Size and Forecast
          6.5.3 Middle East
                   6.5.3.1 Market Size and Forecast
          6.5.4 South America
                   6.5.4.1 Market Size and Forecast
          6.5.5 Africa
                   6.5.5.1 Market Size and Forecast
Chapter 7 Company Profiles
    7.1 Allergan
    7.2 Alcon
    7.3 Eyegate Pharma
    7.4 Otsuka Holdings
    7.5 Santen Pharmaceuticals
    7.6 Bridge Pharma Inc.
    7.7 LLT Bio-Pharma
    7.8 Can-Fite Biopharma
    7.9 Shire/SAR Code Bioscience
    7.10 Novartis

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Related Report